Daoud Faraj
Family Medicine · Dearborn, MINPI 1649213463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 349 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by GSK at 33.2% of the total. Reporting peaked in 2021 at $2,082 and has fallen 99.3% since, to $15 in 2024. Among family medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Novo Nordisk$461
- Amgen$448
- AstraZeneca$397
- Ironwood Pharmaceuticals, Inc$271
- Takeda Pharmaceuticals U.S.A., Inc.$259
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,745100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 95 | $1,913 |
| Novo Nordisk | 39 | $461 |
| Amgen | 24 | $448 |
| AstraZeneca | 22 | $397 |
| Ironwood Pharmaceuticals, Inc | 13 | $271 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $259 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $248 |
| Lilly USA, LLC | 15 | $246 |
| Sanofi-aventis U.S. LLC | 9 | $168 |
| Corcept Therapeutics | 8 | $157 |
| Bayer | 9 | $146 |
| Pfizer | 16 | $137 |
| Boehringer Ingelheim | 8 | $127 |
| Sunovion Pharmaceuticals Inc. | 10 | $123 |
| AbbVie(2 entities) | 8 | $108 |
| Johnson & Johnson | 5 | $86 |
| Merck | 7 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Novartis | 4 | $49 |
| Biohaven Pharmaceuticals, Inc. | 3 | $39 |
| Indivior Inc. | 2 | $34 |
| Pharming Healthcare, Inc. | 2 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Redhill Biopharma Inc. | 2 | $29 |
| Shire North American Group Inc | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Metuchen Pharmaceuticals | 1 | $15 |
| Concordia Pharmaceuticals Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Zogenix Inc. | 1 | $13 |
| Dexcom, Inc. | 1 | $12 |
| Greer Laboratories, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$875
- Repatha$125
- AREXVY$120
How this compares
$5,764 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Single Use SwabAlcohol Antiseptic Pads | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Dearborn
- Howard WrightDearborn$16K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.